GARY GRAF: Open Payments
NPI 1053482174 · TOPEKA, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$107,146 in 284 payments from 13 companies in 2025. Trend: 2023 $189,811 · 2024 $182,419 · 2025 $107,146
Speaker / faculty: $82,872Travel & lodging: $8,041Honoraria: $7,200Consulting: $5,275Food & beverage: $3,716Education: $43
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 166 | $62,314 |
| Novo Nordisk Inc | 39 | $24,371 |
| Averitas Pharma Inc. | 29 | $13,014 |
| Senseonics, Incorporated | 10 | $6,000 |
| Ascensia Diabetes Care Us Inc. | 17 | $516 |
| Amgen Inc. | 3 | $317 |
| Insulet Corporation | 10 | $149 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $125 |
| Mannkind Corporation | 3 | $115 |
| Novartis Pharmaceuticals Corporation | 2 | $103 |
Products named: MOUNJARO, Ozempic, QUTENZA, Eversense, TEPEZZA, Omnipod, Kerendia, AFREZZA.
Industry payments across KS — which companies pay providers there.
